SEC Comment Letter for BIO-PATH HOLDINGS, INC. (BPTH) (CIK 0001133818) (BPTH) — May 21, 2019
BIO-PATH HOLDINGS, INC. (BPTH) (CIK 0001133818)
Date: May 21, 2019 · CIK: 0001133818 · Accession: 0000000000-19-008756
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231537
Letter
May 21, 2019 Peter H. Nielsen Chief Executive Officer Bio-Path Holdings, Inc. 4710 Bellaire Boulevard, Suite 210 Bellaire, TX 77401 Re:Bio-Path Holdings, Inc. Registration Statement on Form S-3 Filed May 16, 2019 File No. 333-231537 Dear Mr. Nielsen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: William R. Rohrlich, II, Esq.
Show Raw Text
May 21, 2019
Peter H. Nielsen
Chief Executive Officer
Bio-Path Holdings, Inc.
4710 Bellaire Boulevard, Suite 210
Bellaire, TX 77401
Re:Bio-Path Holdings, Inc.
Registration Statement on Form S-3
Filed May 16, 2019
File No. 333-231537
Dear Mr. Nielsen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: William R. Rohrlich, II, Esq.